Natural Berry Extract Treatment of Hemangiomas
(Pediaberry Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests PediaBerry™, a powdered mix of berry extracts, on infants with hemangiomas. The treatment is applied on the skin and given orally to help reduce these benign growths.
Who Is on the Research Team?
Gayle Gordillo, MD
Principal Investigator
Indiana University
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive once daily topical and oral gavage dosing of PediaBerry or placebo for hemangioma treatment
Follow-up
Participants are monitored for signs of rebound hemangioma proliferation and other safety measures
What Are the Treatments Tested in This Trial?
Interventions
- PediaBerry
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
Gayle Gordillo
Lead Sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborator
National Institutes of Health (NIH)
Collaborator